Medicare Enrolled

Dr. Michael Brame, M.D.

Urology Physician · Shelby, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1001 N WASHINGTON ST, Shelby, NC 28150
7044822011
In practice since 2006 (19 years)
NPI: 1487667424 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brame from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brame? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brame

Dr. Michael Brame is an urology physician in Shelby, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brame performed 3,661 Medicare services across 1,746 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brame received a total of $5,785 from 27 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brame is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in NC $5,785 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,661
Medicare services
Top 24% in NC for urology physician
1,746
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~193 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
1,500 $5 $12
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
577 $2 $6
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
295 $7 $46
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
211 $112 $351
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
175 $172 $800
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
152 $86 $257
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
136 $59 $174
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
117 $21 $69
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
76 $8 $8
Additional urethral implant in prostate
Placement of an additional implant into the urethra within the prostate gland using an endoscope.
71 $655 $2,300
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
59 $79 $315
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
54 $103 $350
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
45 $6 $209
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
27 $10 $42
Injection, garamycin, gentamicin, up to 80 mg 25 $2 $8
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
23 $19 $300
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
21 $45 $485
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $100 $321
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
19 $41 $214
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
19 $158 $600
Urethral implant insertion in prostate
A single implant is placed into the urethra within the prostate gland using an endoscope.
14 $935 $3,000
Cystoscopy with chemical ablation of bladder
A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue.
13 $283 $2,100
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
12 $299 $1,200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
55.3% medium
44.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,785
Total received (2018-2024)
Avg $826/year across 7 years
Top 27% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,697 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,746
2023
$766
2022
$325
2021
$328
2020
$489
2019
$1,314
2018
$818

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$1,567
Laborie Medical Technologies Corp.
$31
Tolmar, Inc.
$29
Sumitomo Pharma America, Inc.
$25
ABBVIE INC.
$22
Olympus America Inc.
$21
Endo USA, Inc.
$18
Agiliti Surgical, Inc.
$17
Teleflex LLC
$16
Top 3 companies account for 93.2% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$2,216
Astellas Pharma US Inc
$996
NeoTract Inc.
$726
Teleflex LLC
$519
PFIZER INC.
$204
Endo Pharmaceuticals Inc.
$128
Amgen Inc.
$112
Boston Scientific Corporation
$108
Bayer HealthCare Pharmaceuticals Inc.
$85
TOLMAR Pharmaceuticals, Inc.
$85
Sumitomo Pharma America, Inc.
$84
Janssen Biotech, Inc.
$69
BOSTON SCIENTIFIC CORPORATION
$62
Dornier MedTech America, Inc
$60
Avadel Specialty Pharmaceuticals, LLC
$53
Tolmar, Inc.
$48
Olympus America Inc.
$33
Laborie Medical Technologies Corp.
$31
Dendreon Pharmaceuticals LLC
$30
Medtronic USA, Inc.
$24
ABBVIE INC.
$22
Endo USA, Inc.
$18
Agiliti Surgical, Inc.
$17
AbbVie, Inc.
$15
DENTSPLY IH Inc.
$14
RGH Enterprises, Inc.
$13
Coloplast Corp
$12
Top 3 companies account for 68.1% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AMS · ARIS · AVEED · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · ELIGARD · Endocare CryoCare CS System · Erleada · GEMTESA · INTERSTIM · LITHOVUE · LithoVue · LoFric · Lupron Depot · MYRBETRIQ · Medilas H Solvo · Noctiva · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · PROVENGE · Prolia · REZUM · TESTOPEL · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · Xofigo · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Shelby?
Compare urology physicians in the Shelby area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
19
Per 100K population
19.0
County median income
$55,769
Nearest hospital
ATRIUM HEALTH CLEVELAND
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brame is a mixed practice specialist, with above-average Medicare volume (top 24% in NC), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brame experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Brame performed 1,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brame receive payments from pharmaceutical companies?
Yes. Dr. Brame received a total of $5,785 from 27 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brame's costs compare to other urology physicians in Shelby?
Dr. Brame's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brame) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →